EPR21-034: Epidemiology of Diffuse Large B Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL) Patients by Line of Therapy in the United States (US) and Europe (EU)

Authors:
Wenzhen Ge Regeneron Pharmaceuticals Inc., Tarrytown, NY

Search for other papers by Wenzhen Ge in
Current site
Google Scholar
PubMed Close
 PhD
,
Jon E. Arnason Beth Israel Deaconess Medical Center, Boston, MA

Search for other papers by Jon E. Arnason in
Current site
Google Scholar
PubMed Close
 MD
,
Ruben G.W. Quek Regeneron Pharmaceuticals Inc., Tarrytown, NY

Search for other papers by Ruben G.W. Quek in
Current site
Google Scholar
PubMed Close
 PhD
,
Katie Keeven Kantar - Health Division, New York, NY

Search for other papers by Katie Keeven in
Current site
Google Scholar
PubMed Close
 MA
,
Knar Nersesyan Kantar - Health Division, New York, NY

Search for other papers by Knar Nersesyan in
Current site
Google Scholar
PubMed Close
 MA, MS
, and
Gena Kanas Kantar - Health Division, New York, NY

Search for other papers by Gena Kanas in
Current site
Google Scholar
PubMed Close
 MPH, PhD
Volume/Issue:
Volume 19: Issue 3.5
Online Publication Date:
17 Mar 2021
DOI:
https://doi.org/10.6004/jnccn.2020.7742
Restricted access

Corresponding Author: Gena Kanas, MPH, PhD
  • Collapse
  • Expand
Print ISSN:
1540-1405
Online ISSN:
1540-1413
Publisher:
National Comprehensive Cancer Network
Cover Journal of the National Comprehensive Cancer Network
Copyright:
Copyright © 2021 by the National Comprehensive Cancer Network 2021
Article Category:
Abstract
Print Publication Date:
20 Mar 2021
Online Publication Date:
17 Mar 2021

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 5725 1358 208
PDF Downloads 3428 0 0
EPUB Downloads 0 0 0